NRP1 and glioblastoma: Contrarily, Gries et al. established 42 orthotopic xenograft model of glioblastoma (GBM) rat models to verify whether transmembrane receptor neuroproteinase-1 (NRP-1) is a relevant molecular target to promote the anti-vascular effect of photodynamic therapy (VTP) [76].